A subset analysis of the randomised , phase @ , MDS-@ study to evaluate outcomes in patients with International Prognostic Scoring System ( IPSS ) - defined Low - / Intermediate ( Int ) -@ - risk myelodysplastic syndromes ( MDS ) with isolated del ( @q ) .